Domvanalimab Antibody
Domvanalimab (AB154) is a humanized anti-TIGIT antibody developed for cancer research, including esophageal cancer. It functions by blocking the TIGIT immune checkpoint, thereby potentiating antitumor immune responses. Its activity is being investigated in both in vitro assays and in vivo preclinical models.
Product Specifications
Product Name Alternative
GS0154, GS-0154, AB 154, AB154, AB-154, Domvanalimab
Target
Others
Conjugation
Unconjugated
Concentration
3.65 mg/mL
Purity
96.22% (May vary between batches)
Molecular Weight
145.12 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
